Jankalyan Sales Private Limited
About Jankalyan Sales Private Limited
Data last updated:
Jankalyan Sales Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 May 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2019PTC325291. Its GSTIN is 27AAECJ5503G1ZR (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Pritima Santoshkumar Dongare and Amar Diliprao Jamadar.
Its last annual general meeting (AGM) was held on 01 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gut No 27 Flat No C4/103 Dhruv Gokuldham Sunderwadi, Aurangabad, Maharashtra, India – 431007.
As per the financials filed for FY 2025, the company reported a revenue of ₹72.73 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.88 Lakh (net margin 2.6%) and EBITDA of ₹1.95 Lakh (EBITDA margin 2.7%). Revenue has grown at a compounded annual rate (CAGR) of 50% over three years and 24% over five years.
Company details
Contact details
Jankalyan Sales Private Limited's registered office is in Aurangabad, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressGut No 27 Flat No C4/103 Dhruv Gokuldham Sunderwadi, Aurangabad, Maharashtra, India – 431007
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Jankalyan Sales Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Jankalyan Sales is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Jankalyan Sales Private Limited, buy the company report.
Financials of Jankalyan Sales Private Limited
FY 2025 filings availableJankalyan Sales Private Limited reported revenue of ₹72.73 Lakh (up 171% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 24% over five years, including 171% growth in the latest year. EBITDA rose 184% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.95 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.88 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.7% | ||||
| Net Profit Margin | 2.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Jankalyan Sales Private Limited, buy the company report.
Board of directors of Jankalyan Sales Private Limited
Jankalyan Sales has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pritima Santoshkumar Dongare | Director | 15 Feb 2024 | 2 Years 8 Months | Current |
| Amar Diliprao Jamadar Also directs: Jas Ecofusion Private Limited, Hire Global Sentinel & HR Solutions Private Limited, Daldana Foods Private Limited and 1 more | Director | 10 May 2019 | 7 Years 6 Months | Current |
| Sharad Kamlakarao Kolte Also directs: SRM Formulation Private Limited | Director | 10 May 2019 | 7 Years 6 Months | Current |
Peer comparison
Jankalyan Sales Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| J & S Ayurveda Products Private Limited | ₹73.03 Lakh (FY 2025) | Kolkata, West Bengal, India | ||||
| Nsynth Labs Private Limited | ₹73.01 Lakh (FY 2022) | -43.0% | Hyderabad, Telangana, India | |||
| Qualimed Bioscience Private Limited | ₹72.93 Lakh (FY 2024) | 122.0% | Ghatlodiya, Ahmedabad, Gujarat, India | |||
| Dr.Cpr Lifesciences Private Limited | ₹72.87 Lakh (FY 2016) | 201.0% | Hyderabad, Telangana, India | |||
| Marthahan Pharma Private Limited | ₹72.77 Lakh (FY 2025) | -40.0% | Nagercoil, Tamil Nadu, India | |||
| Jankalyan Sales Private Limitedthis company | ₹72.73 Lakh (FY 2025) | ₹1.88 Lakh | 2.6% | 171.0% | Aurangabad, Maharashtra, India | |
| Rumart (India) Private Limited | ₹72.69 Lakh (FY 2025) | 2188.0% | Jabalpur, Madhya Pradesh, India | |||
| Amo Detergent Private Limited | ₹72.49 Lakh (FY 2021) | 21.0% | Kolkata, West Bengal, India | |||
| Gufic Chem Private Limited | ₹72.48 Lakh (FY 2024) | -63.0% | Belgaum, Karnataka, India | |||
| Camy Drugs & Chemicals Private Limited | ₹72.44 Lakh (FY 2025) | 10.0% | Karnal, Haryana, India | |||
| Aloemaa Consumer Private Limited | ₹72.41 Lakh (FY 2024) | 372.0% | Delhi, India |
To see the full peer comparison of Jankalyan Sales Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Jankalyan Sales Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jankalyan Sales Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Jankalyan Sales has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECJ5503G1ZR | Maharashtra | Active | 16 Jul 2019 |
To see the full GST registrations and return filing status of Jankalyan Sales Private Limited, buy the company report.
Recent activity
Jankalyan Sales Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Pritima Santoshkumar Dongare was appointed as Director on 15 Feb 2024.
Frequently asked questions
Jankalyan Sales is an active private limited company based in Aurangabad, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 May 2019 (7+ years old) and is registered under CIN U24304MH2019PTC325291.
Jankalyan Sales has 3 current directors:
- Pritima Santoshkumar Dongare - Director
- Amar Diliprao Jamadar - Director
- Sharad Kamlakarao Kolte - Director
The latest financial statements of Jankalyan Sales on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 01 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Jankalyan Sales is 27AAECJ5503G1ZR, registered in Maharashtra.
The CIN (Corporate Identification Number) of Jankalyan Sales is U24304MH2019PTC325291. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jankalyan Sales was incorporated on 10 May 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Jankalyan Sales by revenue are J & S Ayurveda Products Private Limited, Nsynth Labs Private Limited, Qualimed Bioscience Private Limited, Dr.Cpr Lifesciences Private Limited, Marthahan Pharma Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Pritima Santoshkumar Dongare was appointed as Director on 15 Feb 2024. Amar Diliprao Jamadar was appointed as Director on 10 May 2019. Sharad Kamlakarao Kolte was appointed as Director on 10 May 2019.
The registered office of Jankalyan Sales is at Gut No 27 Flat No C4103 Dhruv Gokuldham Sunderwadi, Aurangabad, Maharashtra, India – 431007.
Jankalyan Sales operates in the pharma industry, in the drug formulation and development segment.
Jankalyan Sales can be reached at its registered office: Gut No 27 Flat No C4103 Dhruv Gokuldham Sunderwadi, Aurangabad, Maharashtra, India – 431007.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
